Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.
about
Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantationAlternative donor transplant of benign primary hematologic disordersAdvances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disordersHematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapyHematopoietic stem cell transplantation for sickle cell disease: state of the science.Blood and marrow transplantation for sickle cell disease: is less more?Thalassemia 2016: Modern medicine battles an ancient disease.Cellular therapy for sickle cell diseaseUnrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejeBone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan.
P2860
Q26775513-608DFB88-4F88-4E62-8FDE-A9E95BE7F5CEQ26823398-D9652444-F5E0-48E0-8DF9-28B5E173C87DQ27022561-3FDF7CB6-8574-4208-8B8F-09722E0D8047Q34625467-552408BB-7C77-4A4A-B8C4-AC1C36062571Q36343931-7DB71DEF-4179-4A73-99B3-E75060E44A72Q38247055-431AA472-8F55-4576-A6FB-CAC6B55D739BQ38248808-D7662D5C-1286-4AB5-8A2A-37D0D91A4D80Q38625435-2808FB9B-476D-4394-BB43-82FEA9C25200Q38898163-B675246D-B415-4A5F-B87F-13275A673893Q38977681-255EB3A1-5472-475E-B809-16EDCF5492B0Q38993061-1F1CA0FA-78B5-479B-9573-F4CFD5225985Q40401388-806F8446-7778-4FEA-91F3-63516F4C42D9
P2860
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@en
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@nl
type
label
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@en
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@nl
prefLabel
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@en
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@nl
P2093
P2860
P1476
Unrelated donor allogeneic hem ...... rty mesenchymal stromal cells.
@en
P2093
Angela R Smith
David H McKenna
James B Ball
John E Wagner
Kenneth I Weinberg
Lawrence S Lamb
Rajni Agarwal
Sandhya Kharbanda
Stephanie K Hutchinson
P2860
P304
P356
10.1016/J.BBMT.2013.12.564
P577
2013-12-24T00:00:00Z